Nomura Asset Management Co. Ltd. acquired a new position in iShares NASDAQ Biotechnology Index (NASDAQ:IBB) during the third quarter, according to the company in its most recent filing with the SEC. The fund acquired 3,631 shares of the financial services provider’s stock, valued at approximately $1,211,000.

A number of other hedge funds have also recently modified their holdings of IBB. Bessemer Group Inc. raised its stake in shares of iShares NASDAQ Biotechnology Index by 28.6% in the 2nd quarter. Bessemer Group Inc. now owns 1,574 shares of the financial services provider’s stock valued at $488,000 after purchasing an additional 350 shares in the last quarter. First Trust Advisors LP raised its stake in shares of iShares NASDAQ Biotechnology Index by 0.5% in the 2nd quarter. First Trust Advisors LP now owns 3,426 shares of the financial services provider’s stock valued at $1,062,000 after purchasing an additional 18 shares in the last quarter. Wedbush Securities Inc. raised its stake in shares of iShares NASDAQ Biotechnology Index by 1.5% in the 2nd quarter. Wedbush Securities Inc. now owns 877 shares of the financial services provider’s stock valued at $272,000 after purchasing an additional 13 shares in the last quarter. Catamount Wealth Management acquired a new stake in shares of iShares NASDAQ Biotechnology Index in the 2nd quarter valued at about $3,795,000. Finally, Adell Harriman & Carpenter Inc. raised its stake in shares of iShares NASDAQ Biotechnology Index by 28.8% in the 2nd quarter. Adell Harriman & Carpenter Inc. now owns 14,548 shares of the financial services provider’s stock valued at $4,511,000 after purchasing an additional 3,253 shares in the last quarter. Hedge funds and other institutional investors own 21.09% of the company’s stock.

Shares of iShares NASDAQ Biotechnology Index (NASDAQ:IBB) opened at $106.60 on Friday. iShares NASDAQ Biotechnology Index has a 12 month low of $87.97 and a 12 month high of $114.17.

COPYRIGHT VIOLATION NOTICE: This news story was originally published by Watch List News and is owned by of Watch List News. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The correct version of this news story can be accessed at https://www.watchlistnews.com/3631-shares-in-ishares-nasdaq-biotechnology-index-ibb-purchased-by-nomura-asset-management-co-ltd/1767206.html.

About iShares NASDAQ Biotechnology Index

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Institutional Ownership by Quarter for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)

Receive News & Ratings for iShares NASDAQ Biotechnology Index Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares NASDAQ Biotechnology Index and related companies with MarketBeat.com's FREE daily email newsletter.